DP Technology

Nov 21, 2024

DP Technology and Lepu Biopharma Announce Milestone Collaboration: Leveraging Advanced Computational Methods to Accelerate ADC Drug Innovation

Nov 19, 2024

RiDYMO® Platform Drives New Breakthroughs in highly potent PLK1 Inhibitors Development

Aug 01, 2024

Novel Non-Covalent Hits Against GPX4 Identified Using the RiDYMO® Reinforced Dynamics Platform of DP Technology

Jul 08, 2024

DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Lp-PLA2 Inhibitor for DR and DME

Jul 08, 2024

DP Technology Announces Nomination of Development Candidate, a CNS Penetrable Lp-PLA2 Inhibitor for Alzheimer's Disease

Apr 29, 2024

DP Technology DevDay 2024 Showcases Large Science Models and Announces Open Science Initiative

Jan 30, 2024

DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD

Sep 17, 2020

DP Technology Introduces AI Capabilities in its ESPRIT CAM System